Mizuho Markets Americas’s AbbVie ABBV Stock Holding History

Mizuho Markets Americas’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-120,631	Closed	-$27.6M	–	191
2025 Q4	$27.6M	Buy	120,631 +119,152	+8,056%	+$27.1M	0.53%	46
2025 Q3	$342K	Buy	1,479 +32	+2%	+$6.52K	0.01%	123
2025 Q2	$269K	Sell	1,447 -74,604	-98%	-$13.9M	0.01%	128
2025 Q1	$15.9M	Buy	76,051 +61,774	+433%	+$12M	0.33%	57
2024 Q4	$2.54M	Sell	14,277 -17,730	-55%	-$3.26M	0.05%	169
2024 Q3	$6.32M	Sell	32,007 -4,640	-13%	-$866K	0.13%	90
2024 Q2	$6.29M	Sell	36,647 -26,048	-42%	-$4.31M	0.15%	87
2024 Q1	$11.4M	Buy	62,695 +31,781	+103%	+$5.48M	0.28%	68
2023 Q4	$4.79M	Buy	30,914 +7,737	+33%	+$1.13M	0.13%	101
2023 Q3	$3.45M	Buy	+23,177	New	+$3.4M	0.12%	72

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Mizuho Markets Americas's ABBV Position: Q1 2026 in Review

Mizuho Markets Americas sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 120,631 shares — an estimated $27.6M sold.

Mizuho Markets Americas first reported a position in ABBV in Q3 2023 and held it in 10 quarters. The position peaked at $27.6M in Q4 2025. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Mizuho Markets Americas reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Mizuho Markets Americas sold 120,631 AbbVie shares in Q1 2026, an estimated $27.6M.
Mizuho Markets Americas first reported a position in AbbVie in Q3 2023 and held it in 10 quarters.
Mizuho Markets Americas's AbbVie position peaked at $27.6M in Q4 2025.
4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Mizuho Markets Americas's 13F filing for Q1 2026, filed 14 May 2026.